Lithium and oxidative stress lessons from the MPTP model of Parkinson's disease

Neuroscience Letters

Volumn 516, Issue 1, 2012, Pages 57-61

  Arraf, Zaher ^a,b   Amit, Tamar ^a,b   Youdim, Moussa B H ^a,b   Farah, Raymond ^b,c  

^a Eve Topf and National Parkinson Foundation   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c Rebecca Sieff Government Hospital   (Israel)

Author keywords

Dopaminergic neurons; Lipid peroxidation; Lithium; MPTP; Oxidative stress

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; FREE RADICAL; HYDROGEN PEROXIDE; LITHIUM CHLORIDE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DRUG EFFICACY; DRUG MEGADOSE; ENZYME INACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; LIPID PEROXIDATION; LOW DRUG DOSE; MALE; MOUSE; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; CORPUS STRIATUM; DOPAMINERGIC NEURONS; LITHIUM COMPOUNDS; MALE; MICE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PARKINSONIAN DISORDERS;

EID: 84860260905     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.03.055     Document Type: Article

References (34)

1. 3 on the superoxide dismutase and glutathione peroxidase activities of rat brain, liver and erythrocytes. Biochemistry and Molecular Biology International 1994, 34:1085-1090.
2. Andreassen O.A., Ferrante R.J., Dedeoglu A., Albers D.W., Klivenyi P., Carlson E.J., Epstein C.J., Beal M.F. Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic acid, and MPTP. Experimental Neurology 2001, 167:189-195.
3. Ara J., Przedborski S., Naini A.B., Jackson-Lewis V., Trifiletti R.R., Horwitz J., Ischiropoulos H. Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Proceedings of the National Academy of Sciences of the United States of America 1998, 95:7659-7663.
4. Beal M.F. Experimental models of Parkinson's disease. Nature Reviews 2001, 2:325-332.
5. Ben-Shachar D., Youdim M.B. Intranigral iron injection induces behavioral and biochemical parkinsonism in rats. Journal of Neurochemistry 1991, 57:2133-2135.
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976, 72:248-254.
7. Carrillo M.C., Minami C., Kitani K., Maruyama W., Ohashi K., Yamamoto T., Naoi M., Kanai S., Youdim M.B. Enhancing effect of rasagiline on superoxide dismutase and catalase activities in the dopaminergic system in the rat. Life Sciences 2000, 67:577-585.
8. Chan P., DeLanney L.E., Irwin I., Langston J.W., Di Monte D. Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain. Journal of Neurochemistry 1991, 57:348-351.
9. Chandra J., Samali A., Orrenius S. Triggering and modulation of apoptosis by oxidative stress. Free Radical Biology & Medicine 2000, 29:323-333.
10. de Vasconcellos A.P., Nieto F.B., Crema L.M., Diehl L.A., de Almeida L.M., Prediger M.E., da Rocha E.R., Dalmaz C. Chronic lithium treatment has antioxidant properties but does not prevent oxidative damage induced by chronic variate stress. Neurochemical Research 2006, 31:1141-1151.
11. Erakovic V., Zupan G., Varljen J., Laginja J., Simonić A. Lithium plus pilocarpine induced status epilepticus - biochemical changes. Neuroscience Research 2000, 36:157-166.
12. Esterbauer H., Zollner H. Methods for determination of aldehydic lipid peroxidation products. Free Radical Biology & Medicine 1989, 7:197-203.
13. Esterbauer H., Jurgens G., Quehenberger O., Koller E. Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. Journal of Lipid Research 1987, 28:495-509.
14. Frey B.N., Andreazza A.C., Kunz M., Gomes F.A., Quevedo J., Salvador M., Gonçalves C.A., Kapczinski F. Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2007, 31:283-285.
15. 2-induced cell death. Advances in Pharmacology (San Diego, California) 1998, 42:320-324.
16. Gassen M., Glinka Y., Pinchasi B., Youdim M.B. Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction. European Journal of Pharmacology 1996, 308:219-225.
17. Grunblatt E., Mandel S., Maor G., Youdim M.B. Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss. Journal of Neurochemistry 2001, 77:146-156.
18. Hantraye P., Brouillet E., Ferrante R., Palfi S., Dolan R., Matthews R.T., Beal M.F. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nature Medicine 1996, 2:1017-1021.
19. Kasahara Y., Iwai K., Yachie A., Ohta K., Konno A., Seki H., Miyawaki T., Taniguchi N. Involvement of reactive oxygen intermediates in spontaneous and CD95 (Fas/APO-1)-mediated apoptosis of neutrophils. Blood 1997, 89:1748-1753.
20. Kato T., Horiuchi S., Togari A., Nagatsu T. A sensitive and inexpensive high-performance liquid chromatographic assay for tyrosine hydroxylase. Experientia 1981, 37:809-811.
21. Keller R., Oke A., Mefford I., Adams R.N. Liquid chromatographic analysis of catecholamines routine assay for regional brain mapping. Life Sciences 1976, 19:995-1003.
22. Klivenyi P., Andreassen O.A., Ferrante R.J., Lancelot E., Reif D., Beal M.F. Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity. Neuroreport 2000, 11:1265-1268.
23. Klivenyi P., Clair D.S., Wermer M., Yen H.C., Oberley T., Yang L., Flint Beal M. Manganese superoxide dismutase overexpression attenuates MPTP toxicity. Neurobiology Disease 1998, 5:253-258.
24. Przedborski S., Kostic V., Jackson-Lewis V., Naini A.B., Simonetti S., Fahn S., Carlson E., Epstein C.J., Cadet J.L. MPTP-treated mice: long-lasting loss of nigral TH-ir neurons but not paradoxical sleep alterations. Experimental Brain Research 2008, 186:635-642.
25. Przedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V.L., Dawson T.M. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proceeding of the National Academy of Science USA 1996, 93:4565-4571.
26. Przedborski S., Jackson-Lewis V., Naini A.B., Jakowec M., Petzinger G., Miller R., Akram M. The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety. Journal of Neurochemistry 2001, 76:1265-1274.
27. Przedborski S., Kostic V., Jackson-Lewis V., Naini A.B., Simonetti S., Fahn S., Carlson E., Epstein C.J., Cadet J.L. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. Journal of Neuroscience 1992, 12:1658-1667.
28. Quiroz J.A., Gould T.D., Manji H.K. Molecular effects of lithium. Molecular Interventions 2004, 4:259-272.
29. Savas H.A., Gergerlioglu H.S., Armutcu F., Herken H., Yilmaz H.R., Kocoglu E., Selek S., Tutkun H., Zoroglu S.S., Akyol O. Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes. World Journal of Biological Psychiatry 2006, 7:51-55.
30. Schulz J.B., Matthews R.T., Muqit M.M., Browne S.E., Beal M.F. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. Journal of Neurochemistry 1995, 64:936-939.
31. Shaldubina A., Agam G., Belmaker R.H. The mechanism of lithium action: state of the art, ten years later. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2001, 25:855-866.
32. Vila M., Jackson-Lewis V., Vukosavic S., Djaldetti R., Liberatore G., Offen D., Korsmeyer S.J., Przedborski S. Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Proceeding National Academic of Science USA 2001, 98:2837-2842.
33. von Bohlen und Halbach O., Schober A., Hertel R., Unsicker K. MPTP treatment impairs tyrosine hydroxylase immunopositive fibers not only in the striatum, but also in the amygdala. Neuro-Degenerative Diseases 2005, 2:44-48.
34. Youdim M.B., Arraf Z. Prevention of MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvements of Bcl-2 and Bax. Neuropharmacology 2004, 46:1130-1140.